Page last updated: 2024-11-01

niclosamide and Allodynia

niclosamide has been researched along with Allodynia in 2 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Research Excerpts

ExcerptRelevanceReference
"Niclosamide is a low-nanomolar allosteric antagonist of Group I mGluRs with high selectivity for Group I over homologous Group III mGluRs."1.43Niclosamide is a Negative Allosteric Modulator of Group I Metabotropic Glutamate Receptors: Implications for Neuropathic Pain. ( Ai, N; Welsh, WJ; Wood, RD; Yang, E, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Wang, Y1
Hu, X1
Huang, H1
Jin, Z1
Gao, J1
Guo, Y1
Zhong, Y1
Li, Z1
Zong, X1
Wang, K1
Zhang, L1
Liu, Z1
Ai, N1
Wood, RD1
Yang, E1
Welsh, WJ1

Other Studies

2 other studies available for niclosamide and Allodynia

ArticleYear
Optimization of 4-arylthiophene-3-carboxylic acid derivatives as inhibitors of ANO1: Lead optimization studies toward their analgesic efficacy for inflammatory pain.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Analgesics; Animals; Anoctamin-1; Carboxylic Acids; HEK293 Cells; Humans; Hyperalgesia; Mice; Neopla

2022
Niclosamide is a Negative Allosteric Modulator of Group I Metabotropic Glutamate Receptors: Implications for Neuropathic Pain.
    Pharmaceutical research, 2016, Volume: 33, Issue:12

    Topics: Allosteric Regulation; Analgesics; Animals; Cell Line; Humans; Hyperalgesia; Male; Molecular Docking

2016